Arkolith/Insider Trading/PCVX/Form 4

Wassil Jim

CHIEF OPERATING OFFICERVaxcyte, Inc. (PCVX) · full profile →Form 4 · filed Jul 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$127K
Net Open-Market Flow
-$127K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)516$5.35$3K159K
Jul 1, 2026Sell(S)2K$56.03$100K157K
Jul 1, 2026Sell(S)456$57.47$26K157K
Jul 1, 2026Sell(S)6$57.82$347157K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2026Option exercise(M)516—$071K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001813798-26-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML